{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:33:02Z","timestamp":1782930782461,"version":"3.54.5"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.semcancer.2022.11.010","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:26:18Z","timestamp":1668644778000},"page":"170-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Role of chemokines in HPV-induced cancers"],"prefix":"10.1016","volume":"87","author":[{"given":"Mohd","family":"Israr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"DeVoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Papayannakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent R.","family":"Bonagura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5035","key":"10.1016\/j.semcancer.2022.11.010_bib1","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.1659743","article-title":"Viruses in human cancers","volume":"254","author":"zur Hausen","year":"1991","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob. Health"},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/nrc.2018.13","article-title":"Opportunities and challenges for human papillomavirus vaccination in cancer","volume":"18","author":"Roden","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.semcancer.2022.11.010_bib4","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"issue":"9590","key":"10.1016\/j.semcancer.2022.11.010_bib5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1073\/pnas.80.2.560","article-title":"Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers","volume":"80","author":"Gissmann","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib7","doi-asserted-by":"crossref","DOI":"10.1017\/S0022215100126350","article-title":"Recurrent respiratory papillomatosis--the Manchester experience, 1974-1992","volume":"108","author":"Hartley","year":"1994","journal-title":"J. Laryngol. Otol."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib8","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease","volume":"131","author":"Arbyn","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"issue":"11 Pt. 2 Suppl. 104","key":"10.1016\/j.semcancer.2022.11.010_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.mlg.000148224.83491.0f","article-title":"Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population","volume":"114","author":"Wiatrak","year":"2004","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijporl.2009.09.004","article-title":"The role of HPV type in recurrent respiratory papillomatosis","volume":"74","author":"Donne","year":"2010","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.010_bib12","article-title":"Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir","volume":"34","author":"Fusconi","year":"2014","journal-title":"Acta Otorhinolaryngol. Ital. Organo Uff. Soc. Ital. Otorinolaringol. Chir. Cervico-facciale"},{"issue":"7203","key":"10.1016\/j.semcancer.2022.11.010_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.010_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.semcancer.2022.11.010_bib15","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.semcancer.2022.11.010_bib16","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-14-0160","article-title":"Chemokines in cancer","volume":"2","author":"Chow","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.010_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/cmi.2017.135","article-title":"The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?","volume":"15","author":"Yoshimura","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41589-021-00918-z","article-title":"Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1","volume":"18","author":"Shao","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","article-title":"International union of pharmacology. XXII. Nomenclature for chemokine receptors","volume":"52","author":"Murphy","year":"2000","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.semcancer.2022.11.010_bib22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/107999002760624305","article-title":"Chemokine\/chemokine receptor nomenclature","volume":"22","author":"Bacon","year":"2002","journal-title":"J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res."},{"key":"10.1016\/j.semcancer.2022.11.010_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/978-1-4615-0171-8_2","article-title":"Cytokines and chemokines--their receptors and their genes: an overview","volume":"520","author":"Cameron","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.semcancer.2022.11.010_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/B978-0-7020-6896-6.00010-7","article-title":"Chemokines and chemokine receptors","author":"Murphy","year":"2019","journal-title":"Clin. Immunol. Princ. Pract."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.dci.2003.09.006","article-title":"Chemokines","volume":"28","author":"Laing","year":"2004","journal-title":"Dev. Comp. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12964-020-00589-8","article-title":"CCL2\/CCR2 signaling in cancer pathogenesis","volume":"18","author":"Hao","year":"2020","journal-title":"Cell Commun. Signal. CCS"},{"issue":"10","key":"10.1016\/j.semcancer.2022.11.010_bib27","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3390\/ijms18102088","article-title":"Chemokines from a structural perspective","volume":"18","author":"Miller","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.semcancer.2022.11.010_bib28","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.3390\/ijms22189804","article-title":"Chemokine-directed tumor microenvironment modulation in cancer immunotherapy","volume":"22","author":"Bule","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"328","key":"10.1016\/j.semcancer.2022.11.010_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad7118","article-title":"PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations","volume":"8","author":"Zou","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib32","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1128\/jvi.68.4.2142-2150.1994","article-title":"Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids","volume":"68","author":"R\u00f6sl","year":"1994","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.010_bib33","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/carcin\/bgu046","article-title":"A CCL2\/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma","volume":"35","author":"Li","year":"2014","journal-title":"Carcinogenesis"},{"issue":"1\u20132","key":"10.1016\/j.semcancer.2022.11.010_bib34","article-title":"Monocyte chemoattractant protein-1 serum levels in patients with breast cancer","volume":"25","author":"Lebrecht","year":"2004","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib35","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI117933","article-title":"The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer","volume":"95","author":"Negus","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib36","first-page":"773","article-title":"Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas","volume":"22","author":"Ohta","year":"2003","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.010_bib37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jnci\/djq044","article-title":"Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth","volume":"102","author":"Zhang","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.010_bib38","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/sj.jid.5700827","article-title":"Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft","volume":"127","author":"Gazzaniga","year":"2007","journal-title":"J. Investig. Dermatol."},{"issue":"7355","key":"10.1016\/j.semcancer.2022.11.010_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2015-310514","article-title":"Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma","volume":"66","author":"Li","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00280-003-0665-1","article-title":"Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells","volume":"52","author":"Niiya","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib42","first-page":"1469","article-title":"Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri","volume":"149","author":"Riethdorf","year":"1996","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<6::AID-IJC2>3.0.CO;2-3","article-title":"Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas","volume":"82","author":"Kleine-Lowinski","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2013.04.015","article-title":"Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer","volume":"130","author":"Hou","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib45","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/ijc.28549","article-title":"Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells","volume":"134","author":"Pahne-Zeppenfeld","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib46","first-page":"426","article-title":"IL-1\u03b2 promotes cervical cancer through activating NF-\u03baB\/CCL-2","volume":"14","author":"Tao","year":"2021","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000137669","article-title":"Association of CCL2 with lymph node metastasis and macrophage infiltration in oral cavity and lip squamous cell carcinoma","volume":"29","author":"Ferreira","year":"2008","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1601-0825.2011.01843.x","article-title":"MCP-1 and CCR2 gene variants in oral squamous cell carcinoma","volume":"18","author":"Bektas-Kayhan","year":"2012","journal-title":"Oral Dis."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088952","article-title":"Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma","volume":"9","author":"Ji","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.010_bib50","first-page":"3299","article-title":"MCP1-induced epithelial-mesenchymal transition in head and neck cancer by AKT activation","volume":"35","author":"Lee","year":"2015","journal-title":"Anticancer Res."},{"issue":"52","key":"10.1016\/j.semcancer.2022.11.010_bib51","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.13523","article-title":"CCL2\/EGF positive feedback loop between cancer cells and macrophages promotes cell migration and invasion in head and neck squamous cell carcinoma","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.010_bib52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"Menten","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.010_bib53","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ijc.21596","article-title":"Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression","volume":"118","author":"Yang","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib54","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2010-09-307249","article-title":"CCL3 (MIP-1\u03b1) plasma levels and the risk for disease progression in chronic lymphocytic leukemia","volume":"117","author":"Sivina","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.010_bib55","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/ijc.28779","article-title":"Crucial involvement of the CCL3-CCR5 axis-mediated fibroblast accumulation in colitis-associated carcinogenesis in mice","volume":"135","author":"Sasaki","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pros.20306","article-title":"Expression of CCL5 (RANTES) and CCR5 in prostate cancer","volume":"66","author":"Vaday","year":"2006","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib57","first-page":"1093","article-title":"The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity","volume":"62","author":"Azenshtein","year":"2002","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib58","first-page":"285","article-title":"Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer","volume":"7","author":"Niwa","year":"2001","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3892\/etm.2015.2911","article-title":"Downregulation of CCR5 inhibits the proliferation and invasion of cervical cancer cells and is regulated by microRNA-107","volume":"11","author":"Che","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3727\/096504008784523667","article-title":"CCR5-Delta32 polymorphism and susceptibility to cervical cancer: association with early stage of cervical cancer","volume":"17","author":"Singh","year":"2008","journal-title":"Oncol. Res."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib61","first-page":"1107","article-title":"Dual role of CCL3\/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense","volume":"18","author":"Silva","year":"2007","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.010_bib62","first-page":"755","article-title":"Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas","volume":"47","author":"Gonz\u00e1lez-Arriagada","year":"2018","journal-title":"J. Oral Pathol. Med. Off. Publ. Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib63","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jcp.21783","article-title":"CCL5\/CCR5 axis promotes the motility of human oral cancer cells","volume":"220","author":"Chuang","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib64","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.V90.3.909","article-title":"Chemokines","volume":"90","author":"Rollins","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib65","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S1679-45082015RB3438","article-title":"Chemokines and immunity","volume":"13","author":"Palomino","year":"2015","journal-title":"Einstein"},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib66","first-page":"554","article-title":"Monocyte chemotactic protein-3","volume":"12","author":"Menten","year":"2001","journal-title":"Eur. Cytokine Netw."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib67","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4049\/jimmunol.175.2.1257","article-title":"A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation","volume":"175","author":"Ali","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jlb.59.1.67","article-title":"Damme, Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1","volume":"59","author":"Proost","year":"1996","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12865-017-0237-5","article-title":"Functional expression of CCL8 and its interaction with chemokine receptor CCR3","volume":"18","author":"Ge","year":"2017","journal-title":"BMC Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.010_bib70","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1074\/jbc.273.8.4289","article-title":"Monocyte chemotactic protein-2 activates CCR5 and blocks CD4\/CCR5-mediated HIV-1 entry\/replication","volume":"273","author":"Gong","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.010_bib71","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41419-019-1748-1","article-title":"Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.semcancer.2022.11.010_bib72","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib73","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3892\/or.2012.1815","article-title":"CC chemokine ligand 7 expression in liver metastasis of colorectal cancer","volume":"28","author":"Cho","year":"2012","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.semcancer.2022.11.010_bib74","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3748\/wjg.v18.i11.1249","article-title":"CCL7 and CCL21 overexpression in gastric cancer is associated with lymph node metastasis and poor prognosis","volume":"18","author":"Hwang","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib75","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ijc.25060","article-title":"Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7","volume":"127","author":"Jung","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2022.11.010_bib76","series-title":"Eosinophil Cytokines in Allergy, Cytokine Effector Functions in Tissues","author":"Lacy","year":"2017"},{"issue":"10","key":"10.1016\/j.semcancer.2022.11.010_bib77","first-page":"3072","article-title":"Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell","volume":"5","author":"Liu","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib78","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2119\/molmed.2012.00284","article-title":"TH2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis","volume":"18","author":"Rosenthal","year":"2012","journal-title":"Mol. Med"},{"issue":"21","key":"10.1016\/j.semcancer.2022.11.010_bib79","doi-asserted-by":"crossref","first-page":"13803","DOI":"10.1074\/jbc.272.21.13803","article-title":"Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7","volume":"272","author":"Yoshida","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib80","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1073\/pnas.95.1.258","article-title":"A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes","volume":"95","author":"Gunn","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"43","key":"10.1016\/j.semcancer.2022.11.010_bib81","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.17982","article-title":"Increased CCL19 expression is associated with progression in cervical cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib82","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/CJI.0b013e31803240fa","article-title":"Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer","volume":"30","author":"Zehbe","year":"2007","journal-title":"J. Immunother."},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.010_bib83","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.oraloncology.2008.06.005","article-title":"Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma","volume":"45","author":"Shang","year":"2009","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib84","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anl.2005.07.019","article-title":"Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses","volume":"33","author":"Tsuzuki","year":"2006","journal-title":"Auris Nasus Larynx"},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.010_bib85","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/jnci\/djn059","article-title":"Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy","volume":"100","author":"Wang","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib86","first-page":"989","article-title":"The chemokine receptor 7 regulates cell adhesion and migration via beta1 integrin in metastatic squamous cell carcinoma of the head and neck","volume":"24","author":"Li","year":"2010","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib87","first-page":"729","article-title":"CCL19-induced chemokine receptor 7 activates the phosphoinositide-3 kinase-mediated invasive pathway through Cdc42 in metastatic squamous cell carcinoma of the head and neck","volume":"25","author":"Zhao","year":"2011","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib88","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3892\/or.2014.3242","article-title":"Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9","volume":"32","author":"Guo","year":"2014","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.semcancer.2022.11.010_bib89","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3892\/ijo.2014.2674","article-title":"CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck","volume":"45","author":"Liu","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"9\u201310","key":"10.1016\/j.semcancer.2022.11.010_bib90","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2119\/2008-00060.DeVoti","article-title":"Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis","volume":"14","author":"DeVoti","year":"2008","journal-title":"Mol. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib91","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1074\/jbc.272.9.5846","article-title":"Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2","volume":"272","author":"Hieshima","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.semcancer.2022.11.010_bib92","doi-asserted-by":"crossref","first-page":"14893","DOI":"10.1074\/jbc.272.23.14893","article-title":"Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC","volume":"272","author":"Baba","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120855","article-title":"Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.semcancer.2022.11.010_bib94","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-15-0732","article-title":"Stromal fibroblasts induce CCL20 through IL6\/C\/EBP\u03b2 to support the recruitment of Th17 cells during cervical cancer progression","volume":"75","author":"Walch-R\u00fcckheim","year":"2015","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.semcancer.2022.11.010_bib95","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1007\/s13277-015-3760-0","article-title":"The key role of astrocyte elevated gene-1 in CCR6-induced EMT in cervical cancer","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib96","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3892\/br.2016.747","article-title":"Emerging role of microRNA-21 in cancer","volume":"5","author":"Feng","year":"2016","journal-title":"Biomed. Rep."},{"issue":"11","key":"10.1016\/j.semcancer.2022.11.010_bib97","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1261\/rna.1034808","article-title":"MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis","volume":"14","author":"Yan","year":"2008","journal-title":"RNA"},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.010_bib98","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/aps.2010.48","article-title":"Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells","volume":"31","author":"Shi","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.semcancer.2022.11.010_bib99","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41419-018-1182-9","article-title":"miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2","volume":"9","author":"Zhao","year":"2018","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib100","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.3390\/ijms22052561","article-title":"MicroRNAs as modulators of oral tumorigenesis-a focused review","volume":"22","author":"Rishabh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib101","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbadis.2011.09.018","article-title":"MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20","volume":"1822","author":"Yao","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0003-9969(02)00167-X","article-title":"Expression of MIP-3alpha\/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma","volume":"48","author":"Abiko","year":"2003","journal-title":"Arch. Oral Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib103","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.oraloncology.2010.11.012","article-title":"Overexpression of macrophage inflammatory protein-3\u03b1 in oral cavity squamous cell carcinoma is associated with nodal metastasis","volume":"47","author":"Chang","year":"2011","journal-title":"Oral. Oncol."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib104","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.185.9.1595","article-title":"Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells","volume":"185","author":"Godiska","year":"1997","journal-title":"J. Exp. Med"},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib105","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L","article-title":"Dendritic cells as a major source of macrophage-derived chemokine\/CCL22 in vitro and in vivo","volume":"31","author":"Vulcano","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.semcancer.2022.11.010_bib106","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/cancers11122004","article-title":"Higher CCL22+ cell infiltration is associated with poor prognosis in cervical cancer patients","volume":"11","author":"Wang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2022.11.010_bib107","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2147\/OTT.S198126","article-title":"M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22\/PI3K\/AKT signaling","volume":"12","author":"Wei","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"12","key":"10.1016\/j.semcancer.2022.11.010_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.27966","article-title":"Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4\/CCL22 in head and neck squamous cell carcinoma","volume":"132","author":"Tsujikawa","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib109","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/cas.14135","article-title":"Cancer-associated fibroblast-derived interleukin-1\u03b2 activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer","volume":"110","author":"Huang","year":"2019","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib110","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.7150\/thno.22536","article-title":"GRO-\u03b1 and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1\/NF\u03baB signaling cascade","volume":"8","author":"Yung","year":"2018","journal-title":"Theranostics"},{"issue":"3 Pt 1","key":"10.1016\/j.semcancer.2022.11.010_bib111","first-page":"L278","article-title":"Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages","volume":"266","author":"Becker","year":"1994","journal-title":"Am. J. Physiol."},{"issue":"10","key":"10.1016\/j.semcancer.2022.11.010_bib112","article-title":"Cloning and sequencing of a new gro transcript from activated human monocytes: expression in leukocytes and wound tissue","volume":"10","author":"Iida","year":"1990","journal-title":"Mol. Cell. Biol."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.010_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2006.04.004","article-title":"Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties","volume":"34","author":"Pelus","year":"2006","journal-title":"Exp. Hematol."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib114","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1203421","article-title":"Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration","volume":"191","author":"Al-Alwan","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/jlb.67.1.53","article-title":"The tumorigenic and angiogenic effects of MGSA\/GRO proteins in melanoma","volume":"67","author":"Haghnegahdar","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib116","doi-asserted-by":"crossref","DOI":"10.21037\/tcr.2019.11.47","article-title":"Correlations of AKIP1, CXCL1 and CXCL2 expressions with clinicopathological features and survival profiles in cervical cancer patients","volume":"9","author":"Wan","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib117","doi-asserted-by":"crossref","DOI":"10.3233\/TUB-200058","article-title":"Annona muricata silver nanoparticles exhibit strong anticancer activities against cervical and prostate adenocarcinomas through regulation of CASP9 and the CXCL1\/CXCR2 genes axis","volume":"43","author":"Gavamukulya","year":"2021","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2015.01.033","article-title":"CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer","volume":"359","author":"Wei","year":"2015","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib119","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20052124","article-title":"CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer","volume":"203","author":"Wang","year":"2006","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.24383","article-title":"CXC-chemokine\/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer","volume":"125","author":"Matsuo","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib121","doi-asserted-by":"crossref","DOI":"10.1159\/000078333","article-title":"Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer","volume":"66","author":"Shintani","year":"2004","journal-title":"Oncology"},{"issue":"36","key":"10.1016\/j.semcancer.2022.11.010_bib122","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.5640","article-title":"Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2012.06.132","article-title":"CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction","volume":"424","author":"Oue","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"34","key":"10.1016\/j.semcancer.2022.11.010_bib124","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.271.34.20545","article-title":"The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor","volume":"271","author":"Ahuja","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib125","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00153.2005","article-title":"GRO family chemokines are specialized for monocyte arrest from flow","volume":"289","author":"Smith","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.29353","article-title":"CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK\/ERK pathway","volume":"235","author":"Qi","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.semcancer.2022.11.010_bib127","article-title":"Analysis of the prognosis and therapeutic value of the CXC chemokine family in head and neck squamous cell carcinoma","volume":"10","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.semcancer.2022.11.010_bib128","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20212403","article-title":"Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma","volume":"41","author":"Guan","year":"2021","journal-title":"Biosci. Rep."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2222.2003.01609.x","article-title":"Expression of the neutrophil-activating CXC chemokine ENA-78\/CXCL5 by human eosinophils","volume":"33","author":"Persson","year":"2003","journal-title":"Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib130","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1021\/bi961999z","article-title":"Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties","volume":"36","author":"Wuyts","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.semcancer.2022.11.010_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2018.08.149","article-title":"CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells","volume":"107","author":"Feng","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.semcancer.2022.11.010_bib132","article-title":"CXCL5 contributes to the tumorigenicity of cervical cancer and is post-transcriptionally regulated by miR-577","volume":"13","author":"Bai","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib133","article-title":"MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6","volume":"23","author":"Shen","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.010_bib134","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-05-4398","article-title":"Down-regulation of CXCL5 inhibits squamous carcinogenesis","volume":"66","author":"Miyazaki","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib135","article-title":"Crosstalk between head and neck cancer cells and lymphatic endothelial cells promotes tumor metastasis via CXCL5-CXCR2 signaling","volume":"35","author":"Lee","year":"2021","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib136","doi-asserted-by":"crossref","DOI":"10.1084\/jem.188.9.1757","article-title":"Endothelial cell \"memory\" of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies","volume":"188","author":"Wolff","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2022.11.010_bib137","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","article-title":"The CXCL8-CXCR1\/2 pathways in cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib138","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171021","article-title":"The clinical and prognostic value of CXCL8 in cervical carcinoma patients: immunohistochemical analysis","volume":"37","author":"Yan","year":"2017","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib139","article-title":"IL-8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells","volume":"15","author":"Jia","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib140","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-013-1679-6","article-title":"Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer","volume":"354","author":"Sheng","year":"2013","journal-title":"Cell Tissue Res."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib141","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11961","article-title":"miR\u2011302c\u20113p and miR\u2011520a\u20113p suppress the proliferation of cervical carcinoma cells by targeting CXCL8","volume":"23","author":"Ding","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.010_bib142","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgs181","article-title":"As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signaling","volume":"33","author":"Li","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1\u20132","key":"10.1016\/j.semcancer.2022.11.010_bib143","article-title":"CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition","volume":"348","author":"Cheng","year":"2014","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib144","article-title":"The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour","volume":"43","author":"Khurram","year":"2014","journal-title":"J. Oral Pathol. Med. Off. Publ. Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib145","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.anl.2007.12.002","article-title":"A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer","volume":"35","author":"Shimizu","year":"2008","journal-title":"Auris Nasus Larynx"},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib146","article-title":"Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan","volume":"18","author":"Liu","year":"2012","journal-title":"Oral is."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib147","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1007\/s13277-014-2193-5","article-title":"Association of IL-8-251A>T polymorphisms with oral cancer risk: evidences from a meta-analysis","volume":"35","author":"Yang","year":"2014","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.semcancer.2022.11.010_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"6021","key":"10.1016\/j.semcancer.2022.11.010_bib149","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/315672a0","article-title":"Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins","volume":"315","author":"Luster","year":"1985","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.semcancer.2022.11.010_bib150","doi-asserted-by":"crossref","first-page":"11064","DOI":"10.18632\/oncotarget.2519","article-title":"IP-10\/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival","volume":"5","author":"Lunardi","year":"2014","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib151","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12935-021-02101-9","article-title":"Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment","volume":"21","author":"Kong","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.semcancer.2022.11.010_bib152","article-title":"CXCL10 produced by HPV-positive cervical cancer cells stimulates exosomal PDL1 expression by fibroblasts via CXCR3 and JAK-STAT pathways","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.semcancer.2022.11.010_bib153","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.bjc.6603790","article-title":"Expression of IP-10 related to angiogenesis in uterine cervical cancers","volume":"96","author":"Sato","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"14","key":"10.1016\/j.semcancer.2022.11.010_bib154","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1128\/MCB.25.14.6247-6258.2005","article-title":"Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression","volume":"25","author":"Zhang","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib155","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2011.472","article-title":"CXCL10 enhances radiotherapy effects in HeLa cells through cell cycle redistribution","volume":"3","author":"Yang","year":"2012","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib156","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3892\/ol.2015.3281","article-title":"Combining CXCL10 gene therapy and radiotherapy improved therapeutic efficacy in cervical cancer HeLa cell xenograft tumor models","volume":"10","author":"Zhao","year":"2015","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.010_bib157","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.oraloncology.2013.05.006","article-title":"Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma","volume":"49","author":"Chang","year":"2013","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib158","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.intimp.2007.10.015","article-title":"Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3\/CXCL10 balance","volume":"8","author":"Chakraborty","year":"2008","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib159","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1007\/s13277-013-1549-6","article-title":"Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue","volume":"35","author":"Rentoft","year":"2014","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib160","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1523-1747.1999.00581.x","article-title":"Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10\/Mig receptor (CXCR3)","volume":"112","author":"Tensen","year":"1999","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.semcancer.2022.11.010_bib161","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/B978-0-12-417197-8.00009-2","article-title":"Constitutively active chemokine CXC receptors","volume":"70","author":"Han","year":"2014","journal-title":"Adv. Pharmacol."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib162","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.184.3.1101","article-title":"A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)","volume":"184","author":"Bleul","year":"1996","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib163","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/bjc.2012.110","article-title":"CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients","volume":"106","author":"Schrevel","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2022.11.010_bib164","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.2147\/CMAR.S228684","article-title":"CXCR7, a prognostic biomarker in cervical squamous cell carcinoma, may be a screening index for treatment options at stages IB1 and IIA1","volume":"11","author":"Zhao","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12032-021-01481-2","article-title":"The CXCL12\/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer","volume":"38","author":"Xu","year":"2021","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.11.010_bib166","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/annonc\/mdl342","article-title":"Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer","volume":"18","author":"Kodama","year":"2007","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib167","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1525-1438.2007.00786.x","article-title":"Study on CXCR4\/SDF-1alpha axis in lymph node metastasis of cervical squamous cell carcinoma","volume":"17","author":"Zhang","year":"2007","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib168","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/ijgc-00009577-200705000-00018","article-title":"CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma","volume":"17","author":"Yang","year":"2007","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib169","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1593\/neo.81508","article-title":"Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration","volume":"11","author":"Walenkamp","year":"2009","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.semcancer.2022.11.010_bib170","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.radonc.2013.06.019","article-title":"Hypoxia and metastasis in an orthotopic cervix cancer xenograft model","volume":"108","author":"Chaudary","year":"2013","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"issue":"12","key":"10.1016\/j.semcancer.2022.11.010_bib171","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.bbagen.2009.08.001","article-title":"Glycosaminoglycans and syndecan-4 are involved in SDF-1\/CXCL12-mediated invasion of human epitheloid carcinoma HeLa cells","volume":"1790","author":"Brule","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib172","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2353\/ajpath.2009.090295","article-title":"Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer","volume":"175","author":"Jaafar","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.semcancer.2022.11.010_bib173","first-page":"2759","article-title":"SIVmac\u2082\u2083\u2089-Nef down-regulates cell surface expression of CXCR4 in tumor cells and inhibits proliferation, migration and angiogenesis","volume":"32","author":"Cai","year":"2012","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib174","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s11307-019-01447-x","article-title":"Therapy-induced changes in CXCR4 expression in tumor xenografts can be monitored noninvasively with N-[ 11C]methyl-AMD3465 PET","volume":"22","author":"Hartimath","year":"2020","journal-title":"Mol. Imaging Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib175","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ajpath.2019.12.004","article-title":"CXCL11-CXCR3 axis mediates tumor lymphatic cross talk and inflammation-induced tumor, promoting pathways in head and neck cancers","volume":"190","author":"Kumaravel","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib176","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-4827(03)00344-6","article-title":"Possible role of stromal-cell-derived factor-1\/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma","volume":"290","author":"Uchida","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"12","key":"10.1016\/j.semcancer.2022.11.010_bib177","first-page":"4525","article-title":"Expression of the CXCL12\/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma","volume":"273","author":"Le\u00f3n","year":"2016","journal-title":"Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. (EUFOS) Affil. Ger. Soc. Oto-Rhino-Laryngol. Head Neck Surg."},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib178","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2004.04.035","article-title":"CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma","volume":"214","author":"Samara","year":"2004","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.semcancer.2022.11.010_bib179","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/carcin\/bgn108","article-title":"CXCL12\/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1\/2\/AP-1 pathway","volume":"29","author":"Tan","year":"2008","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.semcancer.2022.11.010_bib180","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hed.21094","article-title":"Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer","volume":"31","author":"Teng","year":"2009","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib181","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib182","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/79738","article-title":"A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo","volume":"1","author":"Matloubian","year":"2000","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2022.11.010_bib183","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.4049\/jimmunol.172.10.6362","article-title":"The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10","volume":"172","author":"Abel","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib184","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/1568009620666200102123635","article-title":"Hypermethylation of single CpG dinucleotides at the promoter of CXCL13 gene promoting cell migration in cervical cancer","volume":"20","author":"Ma","year":"2020","journal-title":"Curr. Cancer Drug Targets"},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib185","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI11902","article-title":"Bonzo\/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential","volume":"107","author":"Kim","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.semcancer.2022.11.010_bib186","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5732\/cjc.012.10063","article-title":"Expression of the CXCL12\/CXCR4 and CXCL16\/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer","volume":"32","author":"Huang","year":"2013","journal-title":"Chin. J. Cancer"},{"issue":"9","key":"10.1016\/j.semcancer.2022.11.010_bib187","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.21514","article-title":"Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy","volume":"118","author":"Muller","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"20 Pt. 1","key":"10.1016\/j.semcancer.2022.11.010_bib188","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1158\/1078-0432.CCR-06-0535","article-title":"Identification of a gene signature for rapid screening of oral squamous cell carcinoma","volume":"12","author":"Ziober","year":"2006","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2022.11.010_bib189","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-06-1670","article-title":"A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma","volume":"13","author":"Vachani","year":"2007","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2022.11.010_bib190","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/ijc.24920","article-title":"Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice","volume":"126","author":"Pandruvada","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib191","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2014.11.010","article-title":"Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily","volume":"71","author":"Fox","year":"2015","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.semcancer.2022.11.010_bib193","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4049\/jimmunol.158.4.1533","article-title":"Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo","volume":"158","author":"Hedrick","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2022.11.010_bib194","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00014","article-title":"The role of XCR1 and its ligand XCL1 in antigen cross-presentation by murine and human dendritic cells","volume":"3","author":"Kroczek","year":"2012","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.semcancer.2022.11.010_bib195","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1158\/1541-7786.MCR-12-0361","article-title":"The lymphotactin receptor is expressed in epithelial ovarian carcinoma and contributes to cell migration and proliferation","volume":"10","author":"Kim","year":"2012","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.semcancer.2022.11.010_bib196","first-page":"227","article-title":"The role of the chemokine receptor XCR1 in breast cancer cells","volume":"9","author":"Yang","year":"2017","journal-title":"Breast Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2022.11.010_bib197","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/path.2695","article-title":"Functional expression of the chemokine receptor XCR1 on oral epithelial cells","volume":"221","author":"Khurram","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcancer.2022.11.010_bib198","article-title":"Seeing is believing: anti-PD-1\/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy","volume":"1","author":"Tan","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.semcancer.2022.11.010_bib199","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3389\/fphar.2020.00722","article-title":"PD-1\/PD-L1 based combinational cancer therapy: icing on the cake","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.semcancer.2022.11.010_bib200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fonc.2020.00019","article-title":"Schwann cell-derived CCL2 promotes the perineural invasion of cervical cancer","volume":"10","author":"Huang","year":"2020","journal-title":"Front. Oncol."},{"issue":"15","key":"10.1016\/j.semcancer.2022.11.010_bib201","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.3390\/ijms21155186","article-title":"The CCL20-CCR6 axis in cancer progression","volume":"21","author":"Kadomoto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.semcancer.2022.11.010_bib202","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/medicina57111141","article-title":"The role of chemokines in cervical cancers","volume":"57","author":"Garrido","year":"2021","journal-title":"Medicina"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X22002437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X22002437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:04:32Z","timestamp":1760918672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X22002437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":202,"alternative-id":["S1044579X22002437"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2022.11.010","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of chemokines in HPV-induced cancers","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2022.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}